Gene Therapy: Socioeconomic and Ethical Issues: A Roundtable Discussion
Hillman, Alan L.
Brenner, Malcolm K.
Caplan, Arthur L.
Culver, Kenneth W.
Drummold, Michael F.
Freund, Deborah A.
Holmes, Edward W.
Kelley, William N.
Levine, Mark N.
Schondelmeyer, Stephen W.
Wilson, James M.
Human Gene Therapy. 1996 Jun 10; 7(9): 1139-1144.
Gene therapy research has the potential to revolutionize the way in which many human diseases are treated. Despite its enormous potential, roundtable panelists concluded that the field needs time to mature scientifically without pressure to develop a marketable therapeutic product. In addition, health care decision makers, physicians, and the lay public need to be educated on the future medical, economic, and ethical ramifications of gene therapy.
Continuing Education; Drug Industry; Drugs; Education; Financial Support; Gene Therapy; Genetic Research; Government; Government Financing; Health; Health Care; Human Experimentation; Industry; International Aspects; Life; Managed Care Programs; Managed Care; Physicians; Property Rights; Property; Quality of Life; Research; Resource Allocation; Rights; Risks and Benefits; Treatment Outcome; Universities;
Showing items related by title, author, creator and subject.
Hillman, Alan L.; Brenner, Malcolm K.; Caplan, Arthur L.; Carey, John; Champey, Yves; Culver, Kenneth W.; Drummond, Michael F.; Freund, Deborah A.; Holmes, Edward W.; Kelley, William N.; Kolata, Gina; Levine, Mark N.; Levy, Emile; Schondelmeyer, Stephen W. (1996-06-10)